0001225208-19-003773.txt : 20190226
0001225208-19-003773.hdr.sgml : 20190226
20190226191052
ACCESSION NUMBER: 0001225208-19-003773
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190223
FILED AS OF DATE: 20190226
DATE AS OF CHANGE: 20190226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CANGIALOSI LORETTA V
CENTRAL INDEX KEY: 0001174449
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-03619
FILM NUMBER: 19635185
MAIL ADDRESS:
STREET 1: PFIZER INC. ATTN. CORPORATE SECRETARY
STREET 2: 235 EAST 42ND ST.
CITY: NEW YORK
STATE: NY
ZIP: 10017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PFIZER INC
CENTRAL INDEX KEY: 0000078003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 135315170
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 235 E 42ND ST
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 2125732323
MAIL ADDRESS:
STREET 1: 235 E 42ND ST
CITY: NEW YORK
STATE: NY
ZIP: 10017
FORMER COMPANY:
FORMER CONFORMED NAME: PFIZER CHARLES & CO INC
DATE OF NAME CHANGE: 19710908
4
1
doc4.xml
X0306
4
2019-02-23
0000078003
PFIZER INC
PFE
0001174449
CANGIALOSI LORETTA V
PFIZER INC.-CORP. SECRETARY
235 EAST 42ND ST.
NEW YORK
NY
10017
1
Sr. Vice President, Controller
Common Stock
2019-02-23
4
M
0
30864.0000
21.0300
A
115139.0000
D
Common Stock
2019-02-23
4
F
0
7756.0000
42.9600
D
107383.0000
D
Common Stock
2019-02-23
4
F
0
9610.0000
41.9100
D
97773.0000
D
Common Stock
2019-02-25
4
F
0
1759.0000
43.0800
D
96014.0000
D
Common Stock
2098.0000
I
By Rule 16b-3 Plan
Stock Appreciation Rights
21.0300
2019-02-23
4
M
0
30864.0000
0.0000
D
2019-02-23
2019-02-23
Common Stock
30864.0000
0.0000
D
The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
Price is the closing price of Pfizer common stock on February 22, 2019
The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).
Susan E. Grant, by power of atty., for Loretta V. Cangialosi
2019-02-26